Today's top medical abstracts
Rheumatology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Rheumatology
For Practicing
Rheumatologists
Conferences
Jobs
Newsletters
My Library
Topics in
Rheumatology
        Amyloidosis
        Autoimmune/Heritable
        Basic Science/Genetics
        Bone Metabolism
        Chr Fatigue/Fibromyalgia
        Clinical Pharmacology
        Connective Tissue Dz
        Diagnostics/Radiology
        Economics of Medicine
        Gout and Hyperuricemia
        Infectious Arthritis
        Osteoarthritis
        Other Arthritis
        Pediatric Rheumatology
        Popular Press
        Rheumatoid Arthritis
        Spondylarthropathies
        Systemic Lupus (SLE)
        Vasculitic Syndromes
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Rheumatologists
Today's Rheumatology News: Pycnogenol Effective In OA Patients
D Scott Cunningham MD, PhD, MDLinx Rheumatology
Today's Rheumatology News: FDA Approves Actemra
D Scott Cunningham MD, PhD, MDLinx Rheumatology
From the Editors: New Clinical-Only Option for MDLinx!
Stephen Smith, MDLinx
  See all
Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
HLA-DRB1 alleles and Henoch-Schönlein Purpura: Susceptibility and severity of disease
Journal of Rheumatology, 04/17/08
Print     Email This Article     Save in My Library   Free Abstract
Soylemezoglu O et al. - Genetic factors from HLA-DRB1 genotypes might be related to the susceptibility to Henoch-Schönlein purpura (HSP) for Turkish children but not to the severity of this disease.

Methods
  • A study to investigate the implications of the HLA-DRB1 locus and the susceptibility to HSP
  • Also to determine if there are associations with joint, gastrointestinal, and renal manifestations of the disease
  • 110 Turkish pts with HSP were studied
  • Pts and ethnically matched controls with respect to age and sex were HLA-DRB1 genotyped using molecular based methods

Results
  • HLA-DRB1 genotype differences between pts with HSP and controls were observed
  • The frequency of HLA-DRB1*11/14 was higher and the frequency of HLA-DRB1*10/17 was lower in pts with HSP vs controls
  • No HLA-DRB1 associations with gastrointestinal and renal manifestations were found
  • In contrast, HLA-DRB1*11 positivity was increased and HLA-DRB1*14 positivity reduced in HSP pts with joint manifestations
  • Also, HLA-DRB1*13 positivity was found to be increased in pts with nephrotic proteinuria

Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.